|
MRPL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.095800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.187700E-02 |
| Normal-vs-Stage2 |
9.594000E-01 |
| Normal-vs-Stage3 |
3.651600E-01 |
| Normal-vs-Stage4 |
8.883200E-01 |
| Stage1-vs-Stage2 |
2.992800E-01 |
| Stage1-vs-Stage3 |
3.837800E-02 |
| Stage1-vs-Stage4 |
5.085200E-01 |
| Stage2-vs-Stage3 |
5.363400E-01 |
| Stage2-vs-Stage4 |
9.040200E-01 |
| Stage3-vs-Stage4 |
4.216800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.159000E-01 |
| Normal-vs-AfricanAmerican |
1.425810E-01 |
| Normal-vs-Asian |
7.750600E-01 |
| Caucasian-vs-AfricanAmerican |
4.476800E-01 |
| Caucasian-vs-Asian |
5.815000E-01 |
| AfricanAmerican-vs-Asian |
3.797600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.370500E-02 |
| Normal-vs-Female |
2.428400E-01 |
| Male-vs-Female |
1.730070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.834000E-01 |
| Normal-vs-Extreme_Weight |
1.445030E-01 |
| Normal-vs-Obese |
4.182200E-01 |
| Normal-vs-Extreme_Obese |
8.845400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.173400E-01 |
| Normal_Weight-vs-Obese |
8.386800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.005200E-01 |
| Extreme_Weight-vs-Obese |
6.189200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.980600E-01 |
| Obese-vs-Extreme_Obese |
8.703800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.097800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.019400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.274600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.421400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.761900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.391750E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.775800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.884800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.345200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.942200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.224200E-02 |
| Normal-VS-Type2 PRCC |
4.074200E-01 |
| Normal-VS-KIRP CIMP |
1.127530E-02 |
| Normal-VS-Unclassified PRCC |
5.397400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.591800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.167300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
6.601600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.159480E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.305000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.425800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.302400E-03 |
| Normal-vs-N1 |
2.803500E-02 |
| Normal-vs-N2 |
1.645370E-01 |
| N0-vs-N1 |
2.026800E-04 |
| N0-vs-N2 |
3.781200E-01 |
| N1-vs-N2 |
3.400500E-02 |
|
|
